ATE181670T1 - Melatonin enthaltende arzneimittel - Google Patents

Melatonin enthaltende arzneimittel

Info

Publication number
ATE181670T1
ATE181670T1 AT92303674T AT92303674T ATE181670T1 AT E181670 T1 ATE181670 T1 AT E181670T1 AT 92303674 T AT92303674 T AT 92303674T AT 92303674 T AT92303674 T AT 92303674T AT E181670 T1 ATE181670 T1 AT E181670T1
Authority
AT
Austria
Prior art keywords
melatonin
profile
diluent
coating
combination
Prior art date
Application number
AT92303674T
Other languages
English (en)
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24802245&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE181670(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Application granted granted Critical
Publication of ATE181670T1 publication Critical patent/ATE181670T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT92303674T 1991-05-09 1992-04-23 Melatonin enthaltende arzneimittel ATE181670T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69771491A 1991-05-09 1991-05-09

Publications (1)

Publication Number Publication Date
ATE181670T1 true ATE181670T1 (de) 1999-07-15

Family

ID=24802245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92303674T ATE181670T1 (de) 1991-05-09 1992-04-23 Melatonin enthaltende arzneimittel

Country Status (11)

Country Link
US (2) US5500225A (de)
EP (1) EP0518468B1 (de)
JP (1) JPH072694A (de)
AT (1) ATE181670T1 (de)
DE (2) DE122007000073I1 (de)
DK (1) DK0518468T3 (de)
ES (1) ES2134789T3 (de)
GR (1) GR3031257T3 (de)
HK (1) HK1011932A1 (de)
LU (1) LU91378I2 (de)
NL (1) NL300306I1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
ATE141051T1 (de) * 1992-04-07 1996-08-15 Neurim Pharma 1991 Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
WO1995003043A1 (en) * 1993-07-26 1995-02-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Sustained release oral compositions containing melatonin
FR2718020B1 (fr) * 1994-04-01 1996-05-31 Biotec Centre Sa Composition galénique mucoadhésive hétérofonctionnelle.
DE4443175A1 (de) * 1994-12-05 1996-06-13 Jenapharm Gmbh Neue pulsatile Arzneiform
US6469044B1 (en) 1995-02-01 2002-10-22 Neurim Pharmaceuticals (1991) Ltd. Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
WO1996023496A1 (en) * 1995-02-01 1996-08-08 Neurim Pharmaceuticals (1991) Ltd. Use of melatonin for treating patients suffering from drug addiction
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
EP0833636B1 (de) * 1995-06-07 2006-08-23 PLIVA d.d. Verfahren zur inhibition einer neoplastischen krankheit in saeugetieren
US5792748A (en) * 1995-06-07 1998-08-11 The General Hospital Corporation Method for inhibiting neoplastic disease in mammals
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
DE19631084A1 (de) 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
DE69904257T2 (de) * 1999-01-20 2003-04-17 Nutricia Nv Säuglingsnährpräparat
PT1272177E (pt) * 2000-01-05 2007-07-11 Neurim Pharma 1991 Método e formulação para o tratamento da resistência aos antihipertensos e condições associadas.
US20020119191A1 (en) * 2000-04-24 2002-08-29 Hitoo Nishino Pharmaceutical or food composition for treatment or prevention of brain edema
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
US7365238B2 (en) * 2002-02-19 2008-04-29 The Procter And Gamble Company Absorbent article having a dehydration indicator
KR100501827B1 (ko) * 2002-09-24 2005-07-20 한국화학연구원 다층 코팅법을 이용한 멜라토닌 함유 타게팅 약물 전달 기구
US6703412B1 (en) * 2002-09-27 2004-03-09 Holly A. Rosenthal Method of treating sleeplessness with melatonin on an acute basis
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
MXPA06009377A (es) * 2004-02-20 2007-03-07 Lifescape Biosciences Inc Composiciones y metodos para regulacion del sueno.
EP2124907B1 (de) 2007-03-19 2018-05-30 Vita Sciences, Llc Transdermales pflaster und verfahren zur verabreichung von vitamin b12
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
PL2672981T3 (pl) 2011-02-11 2018-09-28 Zx Pharma, Llc Wielocząstkowe preparaty l-mentolu i powiązane sposoby
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US9572528B1 (en) 2012-08-06 2017-02-21 Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center Monitor for SIDS research and prevention
FR3000896B1 (fr) 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
WO2014175852A1 (en) 2013-04-23 2014-10-30 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
EP3206665B1 (de) * 2014-10-13 2020-02-26 Worphmed Srl Anhydrische flüssige melatoninzusammensetzung
CN104546777A (zh) * 2014-12-16 2015-04-29 深圳翰宇药业股份有限公司 美乐托宁缓释组合物的制备方法、美乐托宁缓释片的制备方法
NL2015272B1 (en) * 2015-08-05 2017-05-02 Versailles B V Melatonin formulations and methods for preparation and use.
EP3777842A1 (de) * 2016-10-31 2021-02-17 Neurim Pharmaceuticals Ltd. Melatonin-minitabletten und verfahren zur herstellung davon
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
WO2019038586A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited PHARMACEUTICAL COMPOSITION OF MELATONIN
CN113072479A (zh) * 2021-03-26 2021-07-06 罗田县新普生药业有限公司 一种从褪黑素结晶母液中提取褪黑素的方法
WO2023134856A1 (de) * 2022-01-13 2023-07-20 Paditz Ekkehart Säuglingsnahrung und verfahren zu deren herstellung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5584503A (en) * 1978-12-19 1980-06-25 Teijin Ltd Preparing cellulose ester based selective permeable membrane
CA1151862A (en) * 1980-01-24 1983-08-16 Thomas J. Fogarty Flexible calibrator
US4855325A (en) * 1985-01-16 1989-08-08 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
DE3466215D1 (en) * 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
US4654361A (en) * 1986-01-27 1987-03-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Method of lowering intraocular pressure using melatonin
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
EP0330652A1 (de) * 1987-02-13 1989-09-06 GRAZIOSI, Maurizio System um schuhunterteile atoxisch zu machen
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
GB8727099D0 (en) * 1987-11-19 1987-12-23 Cellena Cell Eng A G Compositions containing melantonin/homologues
FR2630005B1 (fr) * 1988-04-14 1991-11-29 Goupil Jean Jacques Nouveau medicament anti-depresseur contenant du 5-methoxypsoralene
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
US5151446A (en) * 1989-09-25 1992-09-29 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
JPH03145419A (ja) * 1989-10-31 1991-06-20 Shiseido Co Ltd 紫外線老化の防御薬剤

Also Published As

Publication number Publication date
DK0518468T3 (da) 2000-01-31
EP0518468A1 (de) 1992-12-16
JPH072694A (ja) 1995-01-06
GR3031257T3 (en) 1999-12-31
LU91378I2 (en) 2008-01-23
DE69229490D1 (de) 1999-08-05
HK1011932A1 (en) 1999-07-23
EP0518468B1 (de) 1999-06-30
ES2134789T3 (es) 1999-10-16
DE122007000073I1 (de) 2008-01-31
US5500225A (en) 1996-03-19
US5498423A (en) 1996-03-12
DE69229490T2 (de) 2000-02-17
NL300306I1 (nl) 2008-01-02

Similar Documents

Publication Publication Date Title
ATE181670T1 (de) Melatonin enthaltende arzneimittel
DE69431729T2 (de) Bromocryptin enthaltende mittel mit beschleunigter freisetzung
DK0494972T3 (da) Brusedosisform samt fremgangsmåde til administration heraf
PT100973A (pt) Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
AP9400645A0 (en) Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release sold dosage forms of medicaments prepared thereby.
NO306377B1 (no) Doseform for avgivelse av et medikament
YU215090A (sr) Formulacija u obliku pilule za kontrolisano oslobađanje
DK515489A (da) Dispergerbar laegemiddelformulering
GR3006091T3 (de)
DE3778008D1 (de) Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
KR890701087A (ko) 부스피론 및 그의 염의 경구 투여용 제제
NO934832L (no) Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose
DZ3208A1 (fr) Comprimes faiblement doses et procédé de préparation.
DK0615439T3 (da) Iburprofenholdigt retard-lægemiddel og dets anvendelse
KR930017579A (ko) 신경 보호제
IL98199A0 (en) Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat
MX9205084A (es) Receptor mutante del factor de crecimiento y medicamento que lo contiene
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
DE505608T1 (de) Alpha-ergocryptine enthaltende pharmazeutische zusammensetzungen mit nervenschuetzender wirkung.
DK117291D0 (da) Doseringsform til oral indgift af laegemiddelstoffer
NO892010D0 (no) Fremgangsmaate for administrering av legemiddelet deprenylslik at farene for bivirkninger minimaliseres.
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids
GB9218422D0 (en) Device for administering single doses of medicament
DK493887A (da) Buccal formulering